NEW PRODUCTS
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 24017 | AMG-193 | 2790567-82-5 | 98.62%; EE 98.28% |  |
| AMG-193 is an oral, small-molecule, methylthioadenosine-cooperative inhibitor of the | ||||
| 20638 | ATH434 mesylate | 2387898-69-1 | ≧98.0% |  |
| ATH434, is an oral agent designed to inhibit the aggregation of pathological proteins | ||||
| 20633 | STX-478 | 2883540-92-7 | ≧98.0% |  |
| STX-478 is a second generation, mutant-selective, oral PI3Ka small molecule allosteri | ||||
| 24084 | Iclepertin (BI-425809) | 1421936-85-7 | ≧98.0% | _1421936-85-7.png) |
| Iclepertin (BI-425809) is an oral, small-molecule inhibitor of GlyT-1for the treatmen | ||||
| 20471 | FHD-286 | 2671128-05-3 | ≧98.0% |  |
| FHD-286 is an oral, small-molecule, selective, allosteric inhibitor of BRG1 and BRM i | ||||
| 20657 | Zilurgisertib | 2173389-57-4 | ≧98.0% |  |
| Zilurgisertib (earlier known as INCB 00928) is an activin receptor-like kinase-2 (ALK | ||||
| 20549 | STC-15 | 2648257-56-9 | ≧98.0% |  |
| STC-15 is a first-in-class inhibitor of RNA modification and is the first ever RNA me | ||||
| 23122601 | Navacaprant ( BTRX-335140 ) | 2244614-14-8 | ≧98.0% | _2244614-14-8.png) |
| Navacaprant (NMRA-335140, BTRX-140) is an oral, selective, reversible, small-molecule | ||||
| 171680 | Bexotegrast ( PLN-74809 ) | 2376257-44-0 | ≧98.0% |  |
| Bexotegrast (Synonyms: PLN-74809) is a small-molecule, dual selective inhibitor of α | ||||
| 1711225 | Fosgonimeton (ATH-1017) | 2093305-05-4 | ≧98.0% | _2093305-05-4.png) |
| Fosgonimeton (ATH-1017) is a small molecule which enhance the activity of hepatocyte | ||||
| 52013 | ONX-0914 ( PR-957 ) | 960374-59-8 | ≧95.0% |  |
| ONX-0914, an inhibitor of the LMP7 and LMP2 subunits of immunoproteasomes, has activi | ||||
| 24067 | PBT434 Hydrobromide | 1232841-78-9 | ≧98.0% |  |
| PBT434, also known as ATH434 , is a novel, brain-penetrant, inhibitor of α-synuclein | ||||